(106-19) A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastroesophageal Adenocarcinoma (Phase 2 clinical trial, appropriate for patients with HER2-expressing gastroesophageal adenocarcinoma.)
(108-19) ROMAN: A Study to Investigate the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer (Phase 3 clinical trial, appropriate for patients with oral mucositis.)
(131-17) A Phase 1/2 Safety Study of Intratumorally Administered INT230-6 in Adult Subjects with Advanced Refractory Cancers (Phase 1 clinical trial, appropriate for patients with solid tumors.)
(134-17) A Phase IIa trial of sEphB4-HSA in combination with Anti PD-1 Antibody (Pembrolizumab, MK-3475) in patients with non-small cell lung and head/neck cancer (Phase 2 clinical trial, appropriate for patients with lung, head or neck cancer.)
(152-17) Ascending Doses of AZD6738 in Combination With Chemotherapy and/or Novel Anti Cancer Agents (Phase 1/2 clinical trial, appropriate for patients with advanced solid malignancies.)
(157-17) FID-007 in Treating Participants With Advanced Solid Tumors (Phase 1 clinical trial, appropriate for patients with advanced solid malignancies.)
(214-17) A Phase 1/2 First-in-human Study of BMS-986258 Alone and in Combination with Nivolumab in Advanced Malignant Tumors (Phase 1/2 clinical trial, appropriate for patients with advanced malignant tumors.)
Certain clinical trials may not be listed on ClinicalTrials.gov. To learn more about these or other clinical trials, please call 949-764-5543 or contact us online.